x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

IRB Services for Sponsors and CROs

Regardless of your project’s scope, therapeutic niche, or number of investigators, Advarra will support your studies with the right people, processes, and technology to help you advance clinical research: safer, smarter, faster.

Test tube and vaccines and pharmaceutical drugs

Advarra has been an excellent partner to PRA as we work to streamline the study startup process, improve transparency, and maintain the highest standards of human subject protection.

Jen Watford

Global Study Startup, PRA Health Sciences

Global CRO Drives Study Startup Efficiency by Converting Local IRB Sites to Central IRB Review

Optimizing Research Performance and Enabling Compliant, Safe, and Transparent Trials


Rely on outstanding service, real-time reporting, and consistent reviews

Checkmark

A central point of contact who knows you and your studies

Checkmark

Clear, coordinated communications

Checkmark

One study startup process for all sites

Checkmark

Web-based technologies available anytime, anywhere

Meet Critical Study Milestones with Rapid Turnaround Times

Advarra provides prompt, accurate, and thorough reviews. We can work with you to meet demanding timelines.

4
business days from submission to decision

New protocol and initial informed consent for multisite studies (full board review)

1-2
business days from submission to decision

New protocols and initial informed consent (minimal risk review)

1
business day from submission to decision

New site for a multisite study

Expert Oversight

Ensure Expert Oversight for All Types of Research

Leveraging deep regulatory expertise and broad experience across all major therapeutic areas and research phases, including specialized review services for oncology research, Advarra helps you navigate the changing regulatory requirements, ensuring appropriate participant protections.

In addition to supporting pharmaceutical and biopharmaceutical product studies, Advarra has reviewed all device study categories. Our IRB review experience includes implantable and portable devices, diagnostic tools, mobile medical devices, human factors testing, and HUD/HDE studies. Our experts are also adept at decentralized trial modalities and early phase research. 

Scalable Services

Simplify Startup for Large and Multinational Megatrials

Advarra recognizes the unique needs associated with large clinical trials: high-volume site reviews, milestone achievements, priority sites, fast turnaround, steady communication with the IRB, and more. Even as trials progress through Phase IV, Advarra can scale review and compliance services and tap an outstanding network of experts for particularly large, unique, or complex projects.

Study Feasibility

Study Feasibility and Site Selection Support

Advarra offers Performance Data Quicklist (PDQ), the tool helping sponsors and CROs accelerate study startup and gain unparalleled visibility into site performance. More than a list of sites, PDQ provides detailed site performance metrics synthesized from actual completed studies.

Study Startup Efficiencies

Our early engagement services help you start studies faster and enroll more sites to meet critical milestones.

  • The greatest institutional reach of any IRB: Advarra has working relationships with over 3,500 institutional sites, more than any other central IRB. Request our institutions list to see if your preferred sites already work with us (chances are, they do).
  • Regulatory consultations/protocol writing: Advarra Consulting can help design or write your study protocol, or craft a compliant ICF for the trial.
  • Site identification and feasibility support: Augment existing site databases and increase study resources to identify high-performing sites with Advarra’s Performance Data Quicklist (PDQ) service. More than just a list of sites, PDQ simplifies study startup and offers unparalleled visibility into site performance.
  • Rapid site activation: Onboard sites in less than one day and shrink total IRB review and approval time with Advarra’s IRB-Ready® approach.
  • Draft review and advisory opinion: Increase the likelihood of a smooth, efficient review with your formal study submission. This robust review of your draft protocol can address questions about study design, participant protections, and regulatory requirements.
  • Real-time study information and reports: Stay up-to-date on the IRB review process with Advarra’s CIRBI Platform. No need to search through your emails — CIRBI manages IRB communications.

Learn More About Study Startup Efficiencies

Technology Enabled IRB Processes for Streamlined Reviews

Advarra Integrated Solutions

Ready to make your research safer, smarter, faster?